Top News

FEATURED

ASCO GU 2019 Symposium

Our complete coverage of the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco, CA.

Immunotherapy in Glioblastoma: Peaks and Pits

New studies in glioblastoma highlight how PD-1 inhibitors could simultaneously prompt an immune response and steer the selection of tumor clones that evade immune recognition.

Fact Sheet: Liquid Biopsies in Cancer

This fact sheet describes liquid biopsies and their uses in oncology.

Radical Prostatectomy vs Watchful Waiting

At 23 years of follow-up, the cumulative incidence of death was higher among patients in the watchful waiting group compared with those in the radical prostatectomy group.

Predictions in Medicine 2019: What's Ahead

A new partner in the fight to cure cancer. A once-unlikely source for combatting clinician burnout. These are some of the advances we and other experts predict will affect oncologists and their patients in 2019 and beyond. Take a look inside our crystal ball.

Ask the Experts: NSCLC

Cancer Therapy Advisor asked 2 experts to weigh in on recommended treatment modalities for patients with non-small cell lung cancer.

Ask the Experts: STS Clinical Insights

Cancer Therapy Advisor asked 2 experts to weigh in on the latest clinical insights into soft tissue sarcoma.

Ask the Experts: Waldenström Macroglobulinemia

Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with Waldenström macroglobulinemia.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

Immunotherapy in Glioblastoma: Peaks and Pits

Immunotherapy in Glioblastoma: Peaks and Pits

New studies in glioblastoma highlight how PD-1 inhibitors could simultaneously prompt an immune response and steer the selection of tumor clones that evade immune recognition.

Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer

Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer

At 23 years of follow-up, the cumulative incidence of death was higher among patients in the watchful waiting group compared with those in the radical prostatectomy group.

Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing

Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing

"People have shown that the variant-identification quality of WGS is superior to WES," said Dr Gerstein.

Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome

Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome

Researchers identified 15 genes that they said independently predict the survival outcome of patients with kidney renal papillary cell carcinoma.

Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves

Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves

Patient-reported outcomes, or PROs, are going to play a larger role in FDA cancer drug approvals, according to an expert in the field.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs